The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial

Nanna Pilmark, Mark Lyngbæk, Laura Oberholzer, Ida Elkjær, Christina Petersen-Bønding, Katja Kofoed, Christoph Siebenmann, Katja Kellenberger, Gerrit van Hal, Julie Abildgaard, Helga Ellingsgaard, Carsten Ammitzbøl Lauridsen, Mathias Ried-Larsen, Bente Klarlund Pedersen, Katrine B. Hansen, Kristian Karstoft

    Publikation: Bidrag til tidsskriftTidsskriftsartikelForskningpeer review

    Abstract

    BACKGROUND AND AIMS: To assess the interaction between metformin and exercise training on postprandial glucose in individuals with impaired glucose tolerance. MATERIAL AND METHODS: Glucose-intolerant individuals (2-hour oral glucose tolerance test glucose of 7.8-11.0 mmol/l and/or HbA1c of 5.7-6.5% (39-47 mmol/mol) or glucose-lowering-medication naive type 2 diabetes) were randomly allocated to placebo (PLA, n=15) or metformin (MET, n=14), and underwent 3 experimental days: BASELINE - before randomisation, MEDICATION - after 3 weeks of metformin (2 g/day) or placebo treatment, and TRAINING - after 12 weeks of exercise training in combination with MET/PLA treatment. Training consisted of supervised bicycle interval sessions at average 64% of Wattmax for 45 minutes, 4 times/week. Postprandial glucose (mean glucose concentration) during a mixed meal tolerance test (MMTT) was assessed on each experimental day. For within-group differences, a group x time interaction was assessed using 2-way repeated measures analysis of variance. Between-group changes of the outcomes at different time points were compared using unpaired two-tailed Students t-tests. RESULTS: Postprandial glucose improved from BASELINE to TRAINING in both PLA and MET (∆PLA: -0.7[-1.4;0.0] mmol/l, P=0.05 and ∆MET: -0.7[-1.5;-0.0] mmol/l, P=0.03), with no between-group difference (P=0.92). In PLA, the entire reduction was seen from MEDICATION to TRAINING (-0.8[-1.3;-0.1] mmol/l, P=0.01). Conversely, in MET, the entire reduction was observed from BASELINE to MEDICATION (-0.9[-1.6;-0.2] mmol/l, P=0.01). The reductions in mean glucose concentrations during the MMTT from BASELINE to TRAINING were dependent on differential time effects: In PLA, a decrease was observed at t=120 min (P=0.009), whereas in MET, a reduction occurred at t=30 minutes (P<0.001). VO2peak increased 15% (4.6 [3.3;5.9] ml/kg/min P<0.0001) from MEDICATION to TRAINING and body weight decreased (4.0 [-5.2;-2.7] kg, P<0.0001) from BASELINE to TRAINING, with no between-group differences (P=0.7 and P=0.5, respectively). CONCLUSION: Metformin plus exercise training was not superior to exercise training alone in improving postprandial glucose. The differential time effects during the MMTT suggest an interaction between the two modalities.
    OriginalsprogEngelsk
    TidsskriftDiabetologia
    Vol/bind64
    Udgave nummer2
    Sider (fra-til)397-409
    Antal sider13
    ISSN0012-186X
    DOI
    StatusUdgivet - feb. 2021

    Emneord

    • diagnosticering
    • overvægt
    • fysisk aktiv
    • livskvalitet

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial'. Sammen danner de et unikt fingeraftryk.

    Citationsformater